Home > Products > IL13 & IL17 > Recombinant Anti-IL13 x Anti-IL17 Bispecific Antibody (Tandem scFv-Fc)

Recombinant Anti-IL13 x Anti-IL17 Bispecific Antibody (Tandem scFv-Fc)  (CAT#: BSFVF-172)

Recombinant Anti-IL13 x Anti-IL17 Bispecific Antibody (Tandem scFv-Fc) is designed to be expressed as a homodimer, which has 2+2 antigen-binding valency. This format consists of one Fc region and two tandem scFv fragments, in which the anti-IL13/IL17 tandem scFv is fused to the Fc domain. The engineered fragment format is used to extend the half-life. This BsAb can bind and inactivate two ligands simultaneously. It is designed for the research of Asthma therapy.
Datasheet INQUIRY

Specifications

Targets
IL13 & IL17
Type
Constant Domain-extended Bispecific Fragments
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Asthma

Targets

Target 1
IL13
Gene ID
UniProt ID
Alternative Names
IL13; interleukin 13; P600; IL-13; interleukin-13
Target 2
IL17
Gene ID
UniProt ID
Alternative Names
IL17A; interleukin 17A; IL17; CTLA8; IL-17; IL-17A; interleukin-17A; CTLA-8; cytotoxic T-lymphocyte-associated antigen 8; cytotoxic T-lymphocyte-associated protein 8; interleukin 17 (cytotoxic T-lymphocyte-associated serine esterase 8)
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "IL13 & IL17"
See other bsAb targets related to "IL17"

See other bsAb targets related to "IL13"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-IL13 x Anti-IL17 Bispecific Antibody (Tandem scFv-Fc) (BSFVF-172). Click the button below to contact us or submit your feedback about this product.